PULMOTIL PREMIX DIN 02240124
Health Canada record
| Active ingredient(s) | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G |
|---|---|
| Dosage form | Drug Premix |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | 01-Nov-1999 |
| Current status date | 19-Feb-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2022-08-03).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TILMICOSIN (TILMICOSIN PHOSPHATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02513811 | RESPOTIL | MODERN VETERINARY THERAPEUTICS LLC | Solution | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG | Marketed |
| 02461099 | TILMICOSIN 200 | BIO AGRI MIX LP | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
| 02482150 | TILMICOSIN AC | BIO AGRI MIX LP | Solution | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG | Approved |
| 02349507 | TILMOVET PREMIX | HUVEPHARMA EOOD | Drug Premix | TILMICOSIN (TILMICOSIN PHOSPHATE) 200 G | Marketed |
| 02393638 | PULMOTIL AC | ELANCO CANADA LIMITED | Solution | TILMICOSIN (TILMICOSIN PHOSPHATE) 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 20494 | 2018-02-19 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 20227 | 2018-01-04 | Supplement to a New Drug Submission (SNDS) | Change to Prescription Status, Labelling updates |
| 17334 | 2015-09-29 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION, NEW SPECIES: RABBITS |
| 12747 | 2011-11-01 | Supplement to a New Drug Submission (SNDS) | Additional Claims and Concurrent use with Monensin Sodium |
| 9069 | 2007-10-02 | Supplement to a New Drug Submission (SNDS) | NEW INDICATION - AS AN AID IN REDUCING THE SEVERITY OF PORCINE POLYSEROSITIS AND ARTHRITIS ASSOCIATED WITH HAEMOPHILUS PARASUIS (GLASSER'S DISEASE) WHEN FED TO PIGS APPROXIMATELY 7 DAYS PRIOR TO ANTICIPATED OUTBREAK |
| 6585 | 1999-06-17 | New Drug Submission (NDS) |